These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38140802)

  • 1. Predictors of Survival in Friedreich's Ataxia: A Prospective Cohort Study.
    Indelicato E; Reetz K; Maier S; Nachbauer W; Amprosi M; Giunti P; Mariotti C; Durr A; de Rivera Garrido FJR; Klopstock T; Schöls L; Klockgether T; Bürk K; Pandolfo M; Didszun C; Grobe-Einsler M; Nanetti L; Nenning L; Kiechl S; Dichtl W; Ulmer H; Schulz JB; Boesch S;
    Mov Disord; 2024 Mar; 39(3):510-518. PubMed ID: 38140802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
    Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB
    Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Parkinson MH; Mariotti C; Nanetti L; Durr A; Ewenczyk C; Boesch S; Nachbauer W; Klopstock T; Stendel C; Rodríguez de Rivera Garrido FJ; Rummey C; Schöls L; Hayer SN; Klockgether T; Giordano I; Didszun C; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2021 May; 20(5):362-372. PubMed ID: 33770527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.
    Bit-Avragim N; Perrot A; Schöls L; Hardt C; Kreuz FR; Zühlke C; Bubel S; Laccone F; Vogel HP; Dietz R; Osterziel KJ
    J Mol Med (Berl); 2001; 78(11):626-32. PubMed ID: 11269509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS).
    Reetz K; Dogan I; Hohenfeld C; Didszun C; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; Rodríguez de Rivera Garrido FJ; Schöls L; Giordano I; Bürk K; Pandolfo M; Schulz JB;
    Neurology; 2018 Sep; 91(10):e917-e930. PubMed ID: 30097477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked variation in the cardiomyopathy associated with Friedreich's ataxia.
    Dutka DP; Donnelly JE; Nihoyannopoulos P; Oakley CM; Nunez DJ
    Heart; 1999 Feb; 81(2):141-7. PubMed ID: 9922348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typical Friedreich's ataxia without GAA expansions and GAA expansion without typical Friedreich's ataxia.
    McCabe DJ; Ryan F; Moore DP; McQuaid S; King MD; Kelly A; Daly K; Barton DE; Murphy RP
    J Neurol; 2000 May; 247(5):346-55. PubMed ID: 10896266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset features and time to diagnosis in Friedreich's Ataxia.
    Indelicato E; Nachbauer W; Eigentler A; Amprosi M; Matteucci Gothe R; Giunti P; Mariotti C; Arpa J; Durr A; Klopstock T; Schöls L; Giordano I; Bürk K; Pandolfo M; Didszdun C; Schulz JB; Boesch S;
    Orphanet J Rare Dis; 2020 Aug; 15(1):198. PubMed ID: 32746884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed-onset Friedreich's ataxia revisited.
    Lecocq C; Charles P; Azulay JP; Meissner W; Rai M; N'Guyen K; Péréon Y; Fabre N; Robin E; Courtois S; Guyant-Maréchal L; Zagnoli F; Rudolf G; Renaud M; Sévin-Allouet M; Lesne F; Alaerts N; Goizet C; Calvas P; Eusebio A; Guissart C; Derkinderen P; Tison F; Brice A; Koenig M; Pandolfo M; Tranchant C; Dürr A; Anheim M
    Mov Disord; 2016 Jan; 31(1):62-9. PubMed ID: 26388117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing cardiac phenotype in Friedreich's ataxia: The CARFA study.
    Legrand L; Weinsaft JW; Pousset F; Ewenczyk C; Charles P; Hatem S; Heinzmann A; Biet M; Durr A; Redheuil A
    Arch Cardiovasc Dis; 2022 Jan; 115(1):17-28. PubMed ID: 34920960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood.
    Kipps A; Alexander M; Colan SD; Gauvreau K; Smoot L; Crawford L; Darras BT; Blume ED
    Pediatr Cardiol; 2009 Apr; 30(3):306-10. PubMed ID: 18716706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich's ataxia.
    Houshmand M; Panahi MS; Nafisi S; Soltanzadeh A; Alkandari FM
    Mitochondrion; 2006 Apr; 6(2):82-8. PubMed ID: 16581313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.
    Libri V; Yandim C; Athanasopoulos S; Loyse N; Natisvili T; Law PP; Chan PK; Mohammad T; Mauri M; Tam KT; Leiper J; Piper S; Ramesh A; Parkinson MH; Huson L; Giunti P; Festenstein R
    Lancet; 2014 Aug; 384(9942):504-13. PubMed ID: 24794816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac involvement in Friedreich's heredo-ataxia].
    Bertoni PD; Canziani R; Cozzi G; Arancio F; Marforio S
    G Ital Cardiol; 1986 Jan; 16(1):22-9. PubMed ID: 2940141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of longitudinal strain and ejection fraction in Friedreich's ataxia.
    Legrand L; Heuze C; Diallo A; Monin ML; Ewenczyk C; Vicaut E; Montalescot G; Isnard R; Durr A; Pousset F
    Int J Cardiol; 2021 May; 330():259-265. PubMed ID: 33592237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.
    Harding AE
    Brain; 1981 Sep; 104(3):589-620. PubMed ID: 7272714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and functional characteristics of the heart in Friedreich's ataxia.
    Unverferth DV; Schmidt WR; Baker PB; Wooley CF
    Am J Med; 1987 Jan; 82(1):5-10. PubMed ID: 3799693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NfL and pNfH are increased in Friedreich's ataxia.
    Hayer SN; Liepelt I; Barro C; Wilke C; Kuhle J; Martus P; Schöls L;
    J Neurol; 2020 May; 267(5):1420-1430. PubMed ID: 32002649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database.
    Metz G; Coppard N; Cooper JM; Delatycki MB; Dürr A; Di Prospero NA; Giunti P; Lynch DR; Schulz JB; Rummey C; Meier T
    Brain; 2013 Jan; 136(Pt 1):259-68. PubMed ID: 23365101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.